Report Highlights
The global market for catheters should grow from $27.2 billion in 2018 to $34.5 billion by 2023 at a compound annual growth rate (CAGR) of 4.8% for the period of 2018-2023.
Report Includes
- 19 data tables and 52 additional tables
- Industry analysis of the global catheters’ market
- Analyses of the global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of important segments including cardiovascular, urological, neurovascular, intravenous and specialty catheters
- Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the market
- Information on new products being introduced and their future impact on the market
- A relevant patent analysis
- Profiles of leading manufacturers and suppliers of catheters within the market including, Abbott Laboratories, Boston Scientific Corp., Hollister Inc., Medtronic and Stryker
Report Scope
BCC Research analyzed the current catheter market based on (1) projections of worldwide, geographic and type of product market revenues through 2023, (2) current and historical usage, (3) geographical and socio/economic market trends and (4) new applications and products.
The scope of this study encompasses the five major application segments of the catheter market. BCC Research analyzed each type of catheter segment, determined its current market status and examined its impact on future catheter sales. After this analysis, growth forecasts between 2018 and 2023 were projected. Catheter material analysis, regulatory issues and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.
Unless otherwise noted, all revenue values are in U.S. dollars at the time the research was conducted and are not adjusted for inflation.
The reviewed products in the report are not exhaustive and a number of products have been in the market for years.
Analyst Credentials
JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.
Related Reports
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Global Outpatient Clinics Market
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global catheter market has grown to $24.9 billion in 2016 from $23.9 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.7% from 2016 to 2021, reaching nearly $31.3 billion by 2021.
Report Includes
- An overview of the global market for catheters.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of important segments including cardiovascular, urological, neurovascular, intravenous and specialty catheters.
- Help determining the areas of catheter applications poised for growth and the factors driving this growth.
- Information on new products being introduced and their future impact on the market.
- Relevant patent analysis.
- Profiles of leading companies in the catheter industry.
Report Highlights
The global catheter market was nearly $28.6 billion in 2014. This market is expected to grow to $43 billion in 2019, with a compound annual growth rate (CAGR) of 7.1%.
Report Includes
- An overview of the global market for catheters.
- Analyses of global market trends, with data estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Help determining the areas of catheter applications poised for growth and the factors driving this growth
- Information on new products being introduced and their future impact on the market
- Comprehensive profiles of leading companies in the catheter industry.
Report Highlights
The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
Report Highlights
- The global catheter market amounted to $14.5 billion in 2008, and was projected to increase to nearly $18 billion in 2009. It is expected to reach $32.1 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 12.3%.
- The market’s cardiovascular segment is the largest with sales of $6 billion in 2008. That is projected to increase to $7.1 billion in 2009, and to rise at a CAGR of 10.2% to $11.6 billion in 2014.
- The second-largest segment is urology, with revenue of $4.4 billion in 2008, which is expected to reach nearly $6 billion in 2009, and increase to $13.2 billion in 2014, for the highest CAGR among all segments at 17.1%.
Report Highlights
-
The global catheter market is estimated at $13.0 billion for 2007 and forecast to grow at a compound annual growth rate (CAGR) of 8.3% to reach $19.4 billion by 2012.
-
Urologic catheters and diagnostic cardiovascular catheters especially will drive growth within the catheter market.
-
Growth potential in the neurovascular market is strong and waiting to be explored. This market is projected to grow at a CAGR of 9.1% during the forecast period to reach $2.2 billion by 2012.
Report Highlights
-
Fueled by stent revenues, U.S. catheter market sales were forecast to exceed $13.1 billion in 2003. Rising at an AAGR (average annual growthrate) of 12.3%, the market is expected to exceed $23 billion in 2009.
-
Coronary catheter applications should pass $8.2 billion in 2009 with 64% of the projected revenue expected from the sale of drug-elutingstents.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
- U.S. companies received more than 63% of recently granted patents.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More